- Research works
- 6 fractional, all time
- Citations
- 159 28.6 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 6% world 28%
Not ranked overall: Nordic Myeloma Study Group is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Nordic Myeloma Study Group publish most on?
By volume in 2022–2025: Multiple Myeloma Research and Treatments, PI3K/AKT/mTOR signaling in cancer, Lung Cancer Research Studies and Hematopoietic Stem Cell Transplantation.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Multiple Myeloma Research and Treatments Hematology 0 works
- 2 PI3K/AKT/mTOR signaling in cancer Molecular Biology 0 works
- 3 Lung Cancer Research Studies Oncology 0 works
- 4 Hematopoietic Stem Cell Transplantation Hematology 0 works
- 5 Protein Degradation and Inhibitors Molecular Biology 0 works
- 6 Cancer Treatment and Pharmacology Oncology 0 works
- 7 Chronic Myeloid Leukemia Treatments Hematology 0 works
- 8 Bone health and treatments Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Nordic Myeloma Study Group's research output changed?
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Odense
- University of Southern Denmark
- Odense University Hospital
- Odense Municipality
- University College Lillebaelt
- Centre for Cosmology and Particle Physics Phenomenology
- Danish Diabetes Academy
- Nordisk Institut for Kiropraktik og Klinisk Biomekanik
- Syddansk Innovation (Denmark)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.